CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer
Yan Y, Narayan A, Mazinani M, Saeki H, Huang T, Lofland G, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Sukumar S, Pomper MG, Merino VF 2026 Dec Breast Cancer Research 28PET-based risk stratification for adverse events under [225Ac]Ac-PSMA radioligand therapy
Widjaja L, Siegmund SC, Gildehaus FJ, Schmidt-Hegemann NS, Pomper MG, Rowe SP, Bundschuh RA, Wenter V, Sheikh GT, Klimek K, Stief CG, Zacherl MJ, Werner RA, Casuscelli J 2026 Jun European Journal of Nuclear Medicine and Molecular Imaging 53 4360-4373Sex and APOE genotype specific brain regional vulnerability to Alzheimer's Disease
Author Collaboration Mo, Zeng Q, Wang M, Wang E, Zhou X, Xu P, Haroutunian V, Cai D, Zhang B, Spicer K, Longmire CF, Mintzer J, Rojas YG, Sotelo V, Hu W, Jones F, Saklad A, Seshadri S, Boegel A, Hill SJ, Newhouse P, Long R, Long C, Williams A, Acree A, Brawman-Mintzer O, Reichert C, Pomara V, Hernando R, Pomara N, Acothley S, Elayan N, Slaughter ME, Garcia A, Sabbagh M, Gurung M, Le R, Masdeu J, Rosario C, Smith C, Kalowsky T, Rivera E, Okhravi H, Devine R, Yong M, Roglaski E, Kelley B, McColl R, Mathews D, Nguyen T, Pomper M 2026 GeroScienceApplying multimodal dendrimers for prostate cancer theranostics
Lesniak WG, Pomper MG 2026 Nanomedicine 21 1179-1193Deep learning-derived arterial input function for dynamic brain PET
Chen J, Jiang Z, Coughlin JM, Cheong I, Mills KA, Pomper MG, Du Y 2025 Dec NeuroImage 324In-bore MRI-compatible transrectal ultrasound and photoacoustic imaging
Murakami R, Wang Y, Lesniak WG, Tsumura R, Tang Y, Gao S, Tsunoi Y, Nycz CJ, Pomper MG, Fischer GS, Zhang HK 2025 Dec Photoacoustics 46Theranostics 2.0: Target-driven, artificial intelligence-enabled cancer therapy across tumor types
Oldan JD, Anugu A, Islam MZ, Amindarolzarbi A, Werner RA, Pomper MG, Solnes LB, Almaguel F, Moschos S, Viglianti BL, Rowe SP 2025 Dec Diagnostic and Interventional Imaging 106 413-420A pilot study of PSMA-targeted F-18-DCFPyL PET imaging of patients with adenoid cystic carcinoma
Voter AF, Amindarolzarbi A, Shen CJ, Wang J, Kang H, Sharma R, Solnes LB, Pomper MG, Bishop JA, Rowe SP, Kiess AP 2025 Dec Scientific reports 15Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRI
Hodo Y, Tressler CM, Ghaemi B, Thomas R, Webster AS, Bains Williams KN, Li Y, Pomper MG, Dang CV, Bhujwalla ZM, Bulte JW, van Zijl PC, Thomas AM 2025 Dec NPJ Imaging 3Development of an in situ CAR-T cell protocol through optical and PSMA-targeted PET imaging
Zhang N, Seo JW, Robinson E, Rivera-Rodriguez A, Wang J, Guo Y, Czerwinski DK, Kim HR, Tumbale SK, Raie MN, Jan BL, Engudar G, Sallets A, Minn I, Pomper MG, Levy R, Ferrara KW 2025 Jun Proceedings of the National Academy of Sciences of the United States of America 122Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
Mills KA, Du Y, Coughlin JM, Foss CA, Horti AG, Jenkins KR, Skorobogatova Y, Spiro E, Motley CS, Dannals RF, Lesniak WG, Song JJ, Choi YR, Redding-Ochoa J, Troncoso JC, Dawson VL, Kam TI, Pomper MG, Dawson TM 2025 Jun Journal of Clinical Investigation 135Cortical α4β2-nicotinic acetylcholine receptors and cognitive decline in Parkinson's disease
Mills KA, Kuwabara H, Du Y, Gomez G, Motley CS, Skorobogatova Y, Spiro E, Coughlin JM, Lesniak W, Brandt J, Kamath V, Pomper MG, Smith GS 2025 Mar Journal of Parkinson's Disease 15 374-386Annotated Bibliography of Prof. John A. Katzenellenbogen, PhD
Sofia MJ, Moore TW, Pomper MG 2025 Feb Journal of Medicinal Chemistry 68 3911-3942Celebrating John A. Katzenellenbogen, PhD and His Contributions to Science and Medicine
Sofia MJ, Moore TW, Pomper MG 2025 Feb Journal of Medicinal Chemistry 68 3909-3910Effective treatment of human prostate carcinoma xenografts with Single-Dose PSMA-targeted [211At]YF2
Feng Y, Huynh TT, Zheng Y, Banks RL, Pomper MG, Vaidyanathan G, Zalutsky MR 2025 European Journal of Nuclear Medicine and Molecular ImagingCNS Vasculitis in Autoimmune Disease: MR Imaging Findings and Correlation with Angiography
Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB 2024 Dec American Journal of Neuroradiology 45 S76-S86A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissues
Foss CA, Naik R, Das D, Cha H, Minn I, Hall A, Finley P, Wu SJ, Du Y, Dannals RF, Pomper MG, Horti AG 2024 Dec EJNMMI Research 14The cutting edge: Promising oncology radiotracers in clinical development
Oldan JD, Pomper MG, Werner RA, Higuchi T, Rowe SP 2024 Oct Diagnostic and Interventional Imaging 105 400-406Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis
Wong NR, Rubin LH, Harrington CK, Jenkins KR, Shinehouse LK, Yoon M, Kilgore JJ, Soule AR, Lesniak WG, Rowe SP, Horti AG, Kamath V, Dannals RF, Du Y, Pomper MG, Coughlin JM 2024 Aug JAMA Network Open 7A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation
Feng Y, Meshaw RL, Finch SW, Zheng Y, Minn I, Vaidyanathan G, Pomper MG, Zalutsky MR 2024 Jul Nuclear Medicine and Biology 134-135PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
Oldan JD, Almaguel F, Voter AF, Duran A, Gafita A, Pomper MG, Hope TA, Rowe SP 2024 May Cancer Journal 30 176-184A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging
Voter AF, Werner RA, Savas H, Gafita A, Ross AE, Gorin MA, Solnes LB, Pomper MG, Rowe SP, Sheikhbahaei S 2024 Jan Seminars in Nuclear Medicine 54 119-131Prostate-Specific Membrane Antigen-Ligand Therapy: What the Radiologist Needs to Know
Rowe SP, Sadaghiani MS, Gafita A, Sheikhbahaei S, Pomper MG, Young J, Spitz A, Werner RA, Oldan JD, Solnes LB 2024 Jan Radiologic Clinics of North America 62 177-187Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma
Singh R, Thotakura AK, Alati S, Lisok A, Jiang Z, Merino VF, Minn I, Yadav S, Markowski MC, Ged Y, Pavlovich CP, Singla N, Solnes LB, Gorin MA, Pomper MG, Rowe SP, Banerjee SR 2024 Frontiers in Oncology 14Membrane-derived particles shed by PSMA-positive cells function as pro-angiogenic stimuli in tumors
Machado CM, Skubal M, Haedicke K, Silva FP, Stater EP, Silva TL, Costa ET, Masotti C, Otake AH, Andrade LN, Junqueira Md, Hsu HT, Das S, Larney BM, Pratt EC, Romin Y, Fan N, Manova-Todorova K, Pomper M, Grimm J 2023 Dec Journal of Controlled Release 364 312-325Prostate-specific Membrane Antigen Reporting and Data System Version 2.0
Werner RA, Hartrampf PE, Fendler WP, Serfling SE, Derlin T, Higuchi T, Pienta KJ, Gafita A, Hope TA, Pomper MG, Eiber M, Gorin MA, Rowe SP 2023 Nov European urology 84 491-502Imaging Brain Injury in Former National Football League Players
Rubin LH, Du Y, Sweeney SE, O'toole R, Thomas CL, Zandi AG, Shinehouse LK, Brosnan MK, Nam H, Burke ME, Bureau SC, Kilgore JJ, Yoon M, Soule AR, Lesniak WG, Minn I, Rowe SP, Holt DP, Hall AW, Mathews WB, Smith GS, Nowinski CJ, Kassiou M, Dannals RF, Pomper MG, Coughlin JM 2023 Oct JAMA Network Open 6Non-invasive PD-L1 quantification using [ 18 F]DK222-PET imaging in cancer immunotherapy
Mishra A, Gupta K, Kumar D, Lofland G, Sharma AK, Solnes LB, Rowe SP, Forde PM, Pomper MG, Gabrielson EW, Nimmagadda S 2023 Oct Journal for ImmunoTherapy of Cancer 11[18F]FNDP PET neuroimaging test–retest repeatability and whole-body dosimetry in humans
Du Y, Coughlin JM, Amindarolzarbi A, Sweeney SE, Harrington CK, Brosnan MK, Zandi A, Shinehouse LK, Sanchez AN, Abdallah R, Holt DP, Fan H, Lesniak WG, Nandi A, Rowe SP, Solnes LB, Dannals RF, Horti AG, Lodge MA, Pomper MG 2023 Oct European Journal of Nuclear Medicine and Molecular Imaging 50 3659-3665Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer
Alati S, Singh R, Pomper MG, Rowe SP, Banerjee SR 2023 Sep Seminars in Nuclear Medicine 53 663-686First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2
Du Y, Coughlin JM, Brosnan MK, Chen A, Shinehouse LK, Abdallah R, Lodge MA, Mathews WB, Liu C, Wu Y, Minn I, Finley P, Hall AW, Lesniak WG, Dannals RF, Horti AG, Pomper MG 2023 Jul European Journal of Nuclear Medicine and Molecular Imaging 50 2386-2393High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data
Bundschuh RA, Lütje S, Bundschuh L, Lapa C, Higuchi T, Hartrampf PE, Gorin MA, Kosmala A, Buck AK, Pomper MG, Rowe SP, Essler M, Sheikh GT, Werner RA 2023 Mar Clinical nuclear medicine 48 207-212Nucleolin mediates SARS-CoV-2 replication and viral-induced apoptosis of host cells
Merino VF, Yan Y, Ordonez AA, Bullen CK, Lee A, Saeki H, Ray K, Huang T, Jain SK, Pomper MG 2023 Mar Antiviral Research 211Feasibility of Spectra-Based Quantification Algorithm for Non-Linear Photoacoustic Contrast Agents
Serebrennikova L, Gao S, Murakami R, Boinapally S, Ray S, Pomper MG, Zhang HK 2023Re: “Overcoming Challenges Associated with 18F-DCFPyL PET Imaging in Prostate Cancer”
Rowe SP, Voter AF, Werner RA, Zukotynski KA, Pomper MG, Gorin MA, Solnes LB 2023 Canadian Journal of Urology 30 11465-11466Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection
Vaughan HJ, Zamboni CG, Luly KM, Li L, Gabrielson KL, Hassan LF, Radant NP, Bhardwaj P, Selaru FM, Pomper MG, Green JJ 2023 International Journal of Nanomedicine 18 2525-2537Image acquisition and interpretation of 18F-DCFPyL (piflufolastat F 18) PET/CT: How we do it
Rowe SP, Voter AF, Werner RA, Zukotynski KA, Pomper MG, Gorin MA, Solnes LB 2023 Canadian Journal of Urology 30 11432-11437PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
Ismail MS, Peters DE, Rowe SP, Salavati A, Sharma S, Anders RA, Pomper M, Slusher BS, Selaru FM 2023 Clinical and Experimental Gastroenterology 16 237-247The SARS-CoV-2 spike protein binds and modulates estrogen receptors
Solis O, Beccari AR, Iaconis D, Talarico C, Ruiz-Bedoya CA, Nwachukwu JC, Cimini A, Castelli V, Bertini R, Montopoli M, Cocetta V, Borocci S, Prandi IG, Flavahan K, Bahr M, Napiorkowski A, Chillemi G, Ooka M, Yang X, Zhang S, Xia M, Zheng W, Bonaventura J, Pomper MG, Hooper JE, Morales M, Rosenberg AZ, Nettles KW, Jain SK, Allegretti M, Michaelides M 2022 Dec Science Advances 8Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow
Leal JP, Rowe SP, Stearns V, Connolly RM, Vaklavas C, Liu MC, Storniolo AM, Wahl RL, Pomper MG, Solnes LB 2022 Nov Frontiers in Oncology 12Photorealistic three-dimensional visualization of fusion datasets: cinematic rendering of PET/CT
Rowe SP, Pomper MG, Leal JP, Schneider R, Krüger S, Chu LC, Fishman EK 2022 Nov Abdominal Radiology 47 3916-3920System-level optimization in spectroscopic photoacoustic imaging of prostate cancer
Wu Y, Kang J, Lesniak WG, Lisok A, Zhang HK, Taylor RH, Pomper MG, Boctor EM 2022 Sep Photoacoustics 27Molecular imaging in oncology: Current impact and future directions
Rowe SP, Pomper MG 2022 Jul CA Cancer Journal for Clinicians 72 333-352Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
Vaughan HJ, Zamboni CG, Hassan LF, Radant NP, Jacob D, Mease RC, Minn I, Tzeng SY, Gabrielson KL, Bhardwaj P, Guo X, Francisco D, Pomper MG, Green JJ 2022 Jul Science Advances 8Targeted Theranostic 111In/Lu-Nanotexaphyrin for SPECT Imaging and Photodynamic Therapy
Cheng MH, Overchuk M, Rajora MA, Lou JW, Chen Y, Pomper MG, Chen J, Zheng G 2022 Jun Molecular Pharmaceutics 19 1803-1813An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
Lesniak WG, Azad BB, Chatterjee S, Lisok A, Pomper MG 2022 Mar Pharmaceutics 14A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
Chen Y, Minn I, Rowe SP, Lisok A, Chatterjee S, Brummet M, Banerjee SR, Mease RC, Pomper MG 2022 Mar Biomolecules 12In Vivo Functional Assessment of Sodium-Glucose Cotransporters (SGLTs) Using [18F]Me4FDG PET in Rats
Matsusaka Y, Chen X, Arias-Loza P, Werner RA, Nose N, Sasaki T, Rowe SP, Pomper MG, Lapa C, Higuchi T 2022 Molecular Imaging 2022Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer
Voter AF, Werner RA, Pienta KJ, Gorin MA, Pomper MG, Solnes LB, Rowe SP 2022 Expert Review of Anticancer Therapy 22 681-694Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET
Leung KH, Rowe SP, Leal JP, Ashrafinia S, Sadaghiani MS, Chung HW, Dalaie P, Tulbah R, Yin Y, VanDenBerg R, Werner RA, Pienta KJ, Gorin MA, Du Y, Pomper MG 2022 EJNMMI Research 12A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging
Zhang J, Rakhimbekova A, Duan X, Yin Q, Foss CA, Fan Y, Xu Y, Li X, Cai X, Kutil Z, Wang P, Yang Z, Zhang N, Pomper MG, Wang Y, Bařinka C, Yang X 2021 Dec Nature communications 12Whole-body [18 f]fdg pet/ct can alter diagnosis in patients with suspected rheumatic disease
Fröhlich M, Serfling S, Higuchi T, Pomper MG, Rowe SP, Schmalzing M, Tony HP, Gernert M, Strunz PP, Portegys J, Schwaneck EC, Gadeholt O, Weich A, Buck AK, Bley TA, Guggenberger KV, Werner RA 2021 Nov Diagnostics 11CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer
Yan Y, Narayan A, Cho S, Cheng Z, Liu JO, Zhu H, Wang G, Wharram B, Lisok A, Brummet M, Saeki H, Huang T, Gabrielson K, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Yfantis HG, Ambs S, Pomper MG, Sukumar S, Merino VF 2021 Sep Oncogene 40 5752-5763First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET
Coughlin JM, Slania S, Du Y, Shinehouse LK, Brosnan MK, Azad BB, Holt DP, Fan H, Lesniak WG, Minn I, Rowe SP, Dannals RF, Horti AG, Pomper MG 2021 Sep European Journal of Nuclear Medicine and Molecular Imaging 48 3122-3128Cellular and Molecular Imaging with SPECT and PET in Brain Tumors
Sadaghiani MS, Sheikhbahaei S, Rowe SP, Pomper MG, Solnes LB 2021 May Radiologic Clinics of North America 59 363-375Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography
Ordonez AA, Wintaco LM, Mota F, Restrepo AF, Bedoya CA, Reyes CF, Uribe LG, Abhishek S, Alessio FR, Holt DP, Dannals RF, Rowe SP, Castillo VR, Pomper MG, Granados U, Jain SK 2021 Apr Science translational medicine 13CXCR4-directed pet/ct in patients with newly diagnosed neuroendocrine carcinomas
Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester HJ, Meining A, Kircher S, Higuchi T, Pomper MG, Rowe SP, Lapa C, Kircher M 2021 Apr Diagnostics 11Triptolide: Reflections on two decades of research and prospects for the future
Tong L, Zhao Q, Datan E, Lin GQ, Minn I, Pomper MG, Yu B, Romo D, He QL, Liu JO 2021 Apr Natural Product Reports 38 843-86018F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography
Hu F, Morris PJ, Bonaventura J, Fan H, Mathews WB, Holt DP, Lam S, Boehm M, Dannals RF, Pomper MG, Michaelides M, Horti AG 2021 Mar European Journal of Medicinal Chemistry 213Iterative Fluence Compensation and Spectral Unmixing for Spectroscopic Photoacoustic Imaging
Wu Y, Kang J, Lesniak WG, Pomper MG, Boctor EM 2021 IEEE International Ultrasonics Symposium, IUSA three-stage, deep learning, ensemble approach for prognosis in patients with Parkinson’s disease
Leung KH, Rowe SP, Pomper MG, Du Y 2021 EJNMMI Research 11A physics-guided modular deep-learning based automated framework for tumor segmentation in PET
Leung KH, Marashdeh W, Wray R, Ashrafinia S, Pomper MG, Rahmim A, Jha AK 2020 Dec Physics in medicine and biology 65Recent updates and developments in PET imaging of prostate cancer
Rowe SP, Johnson GB, Pomper MG, Gorin MA, Behr SC 2020 Dec Abdominal Radiology 45 4063-4072Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting
Miyahira AK, Pienta KJ, Babich JW, Bander NH, Calais J, Choyke P, Hofman MS, Larson SM, Lin FI, Morris MJ, Pomper MG, Sandhu S, Scher HI, Tagawa ST, Williams S, Soule HR 2020 Nov Prostate 80 1273-1296A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia
Datan E, Minn I, Xu P, He QL, Ahn HH, Yu B, Pomper MG, Liu JO 2020 Sep iScience 23Engineered fragments of the psma-specific 5d3 antibody and their functional characterization
Novakova Z, Belousova N, Foss CA, Havlinova B, Gresova M, Das G, Lisok A, Prada A, Barinkova M, Hubalek M, Pomper MG, Barinka C 2020 Sep International journal of molecular sciences 21 1-21cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis
Cao Q, Lu X, Azad BB, Pomper M, Smith M, He J, Pi L, Ren B, Ying Z, Sichani BS, Morris M, Dilsizian V 2020 May Frontiers in Molecular Biosciences 7Long-Circulating Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostic Agent
Overchuk M, Damen MP, Harmatys KM, Pomper MG, Chen J, Zheng G 2020 May Photochemistry and Photobiology 96 718-724Novel β- And γ-Amino Acid-Derived Inhibitors of Prostate-Specific Membrane Antigen
Kim K, Kwon H, Barinka C, Motlova L, Nam S, Choi D, Ha H, Nam H, Son SH, Minn I, Pomper MG, Yang X, Kutil Z, Byun Y 2020 Mar Journal of Medicinal Chemistry 63 3261-3273Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer
Hapuarachchige S, Huang CT, Donnelly MC, Bařinka C, Lupold SE, Pomper MG, Artemov D 2020 Jan Molecular Pharmaceutics 17 98-108Discussions with leaders: A conversation between Martin pomper and Peter Choyke
Pomper MG, Choyke PL 2020 Jan Journal of Nuclear Medicine 61 3-5PET imaging of soluble epoxide hydrolase in non-human primate brain with [18F]FNDP
Du Y, Minn I, Foss C, Lesniak WG, Hu F, Dannals RF, Pomper MG, Horti AG 2020 EJNMMI Research 10Optimum imaging strategies for advanced prostate cancer: ASCO guideline
Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA 2020 Journal of Clinical Oncology 38 1963-1996Enhancement of radiotherapy with human mesenchymal stem cells containing gold nanoparticles
Pullambhatla M, Rowe SP, Lisok A, Wang Y, Todd GP, Danilkovitch A, Pomper MG 2020 Tomography 6 373-378Comparison of CNN-based Approaches for Detection of COVID-19 on Chest X-ray Images
Leung KH, Rowe SP, Pomper MG, Du Y 2020Evaluation of Musculoskeletal and Pulmonary Bacterial Infections With [124I]FIAU PET/CT
Cho SY, Rowe SP, Jain SK, Schon LC, Yung RC, Nayfeh TA, Bingham CO, Foss CA, Nimmagadda S, Pomper MG 2020 Molecular Imaging 19Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer
Copeland BT, Shallal H, Shen C, Pienta KJ, Foss CA, Pomper MG 2019 Dec Molecular Imaging and Biology 21 1054-1063High-potency ligands for DREADD imaging and activation in rodents and monkeys
Bonaventura J, Eldridge MA, Hu F, Gomez JL, Sanchez-Soto M, Abramyan AM, Lam S, Boehm MA, Ruiz C, Farrell MR, Moreno A, Galal Faress IM, Andersen N, Lin JY, Moaddel R, Morris PJ, Shi L, Sibley DR, Mahler SV, Nabavi S, Pomper MG, Bonci A, Horti AG, Richmond BJ, Michaelides M 2019 Dec Nature communications 10177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy
Banerjee SR, Kumar V, Lisok A, Chen J, Minn I, Brummet M, Boinapally S, Cole M, Ngen E, Wharram B, Brayton C, Hobbs RF, Pomper MG 2019 Nov European Journal of Nuclear Medicine and Molecular Imaging 46 2545-2557Opportunities in precision psychiatry using PET neuroimaging in psychosis
Coughlin JM, Horti AG, Pomper MG 2019 Nov Neurobiology of Disease 131From the Reading Room to the Courtroom—The Use of Molecular Radionuclide Imaging in Criminal Trials
Werner RA, Savoie B, Javadi MS, Pomper MG, Higuchi T, Lapa C, Rowe SP 2019 Nov Journal of the American College of Radiology 16 1612-1617The Correlation Between [68Ga]DOTATATE PET/CT and Cell Proliferation in Patients With GEP-NENs
Yu J, Li N, Li J, Lu M, Leal JP, Tan H, Su H, Fan Y, Zhang Y, Zhao W, Zhu H, Pomper MG, Zhou Y, Yang Z 2019 Oct Molecular Imaging and Biology 21 984-990Impact of Tumor Burden on Quantitative [68Ga] DOTATOC Biodistribution
Werner RA, Hänscheid H, Leal JP, Javadi MS, Higuchi T, Lodge MA, Buck AK, Pomper MG, Lapa C, Rowe SP 2019 Aug Molecular Imaging and Biology 21 790-798The next era of renal radionuclide imaging: novel PET radiotracers
Werner RA, Chen X, Lapa C, Koshino K, Rowe SP, Pomper MG, Javadi MS, Higuchi T 2019 Aug European Journal of Nuclear Medicine and Molecular Imaging 46 1773-1786Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
Minn I, Rowe SP, Pomper MG 2019 Aug The Lancet Oncology 20 e443-e451SPECT/CT Imaging of Mycobacterium tuberculosis Infection with [125I]anti-C3d mAb
Foss CA, Kulik L, Ordonez AA, Jain SK, Michael Holers V, Thurman JM, Pomper MG 2019 Jun Molecular Imaging and Biology 21 473-481Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
Lesniak WG, Mease RC, Chatterjee S, Kumar D, Lisok A, Wharram B, Kalagadda VR, Emens LA, Pomper MG, Nimmagadda S 2019 Jun Molecular Imaging 18Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer
Lesniak WG, Boinapally S, Banerjee SR, Behnam Azad B, Foss CA, Shen C, Lisok A, Wharram B, Nimmagadda S, Pomper MG 2019 Jun Molecular Pharmaceutics 16 2590-2604Novel Functional Renal PET Imaging with 18F-FDS in Human Subjects
Werner RA, Ordonez AA, Sanchez-Bautista J, Marcus C, Lapa C, Rowe SP, Pomper MG, Leal JP, Lodge MA, Javadi MS, Jain SK, Higuchi T 2019 May Clinical nuclear medicine 44 410-411Novel structured reporting systems for theranostic radiotracers
Werner RA, Bundschuh RA, Bundschuh L, Fanti S, Javadi MS, Higuchi T, Weich A, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Herrmann K, Lapa C, Rowe SP 2019 May Journal of Nuclear Medicine 60 577-584Kinetic Control in Assembly of Plasmid DNA/Polycation Complex Nanoparticles
Hu Y, He Z, Hao Y, Gong L, Pang M, Howard GP, Ahn HH, Brummet M, Chen K, Liu HW, Ke X, Zhu J, Anderson CF, Cui H, Ullman CG, Carrington CA, Pomper MG, Seo JH, Mittal R, Minn I, Mao HQ 2019 Apr ACS Nano 13 10161-10178Peptide-based PET quantifies target engagement of PD-L1 therapeutics
Kumar D, Lisok A, Dahmane E, McCoy M, Shelake S, Chatterjee S, Allaj V, Sysa-Shah P, Wharram B, Lesniak WG, Tully E, Gabrielson E, Jaffee EM, Poirier JT, Rudin CM, Gobburu JV, Pomper MG, Nimmagadda S 2019 Feb Journal of Clinical Investigation 129 616-630PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)
Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB, Wu Y, Hall A, LaCourse C, Ahn HH, Nam H, Lesniak WG, Valentine H, Pletnikova O, Troncoso JC, Smith MD, Calabresi PA, Savonenko AV, Dannals RF, Pletnikov MV, Pomper MG 2019 Jan Proceedings of the National Academy of Sciences of the United States of America 116 1686-1691Flash nanocomplexation as a scalable production method for therapeutic pdna/lpei nanoparticles
Liu HW, Hu Y, Minn I, Pomper M, Mao HQ 2019 301Long-circulating prostate-specific membrane antigen-targeted NIR phototheranostic agent
Overchuk M, Harmatys KM, Damen MP, Chen J, Pomper MG, Zheng G 2019[68Ga]-pentixafor PET/CT for CXCR4-mediated imaging of vestibular schwannomas
Breun M, Monoranu CM, Kessler AF, Matthies C, Löhr M, Hagemann C, Schirbel A, Rowe SP, Pomper MG, Buck AK, Wester HJ, Ernestus RI, Lapa C 2019 Frontiers in Oncology 9Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG 2019 Science Advances 5Reproducibility of Cold Uptake Radiomics in 99m Tc-Sestamibi SPECT Imaging of Renal Cell Carcinoma
Ashrafinia S, Jones K, Agorin M, Prowe S, Javadi MS, Pomper MG, Allaf ME, Rahmim A 2018 NovUsing deep-learning to predict outcome of patients with Parkinson's disease
Leung KH, Salmanpour MR, Saberi A, Klyuzhin IS, Sossi V, Jha AK, Pomper MG, Du Y, Rahmim A 2018 NovA hyaluronic acid binding peptide-polymer system for treating osteoarthritis
Faust HJ, Sommerfeld SD, Rathod S, Rittenbach A, Ray Banerjee S, Tsui BM, Pomper M, Amzel ML, Singh A, Elisseeff JH 2018 Nov Biomaterials 183 93-10118F-XTRA PET for enhanced imaging of the extrathalamic α4β2 nicotinic acetylcholine receptor
Coughlin JM, Slania S, Du Y, Rosenthal HB, Lesniak WG, Minn I, Smith GS, Dannals RF, Kuwabara H, Wong DF, Wang Y, Horti AG, Pomper MG 2018 Oct Journal of Nuclear Medicine 59 1603-1608Peptide-Based 68 Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
De Silva RA, Kumar D, Lisok A, Chatterjee S, Wharram B, Venkateswara Rao K, Mease R, Dannals RF, Pomper MG, Nimmagadda S 2018 Sep Molecular Pharmaceutics 15 3946-3952Prostate-specific membrane antigen-targeted photoacoustic imaging of prostate cancer in vivo
Zhang HK, Chen Y, Kang J, Lisok A, Minn I, Pomper MG, Boctor EM 2018 Sep Journal of Biophotonics 11Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent
Plyku D, Mena E, Rowe SP, Lodge MA, Szabo Z, Cho SY, Pomper MG, Sgouros G, Hobbs RF 2018 Jun European Journal of Nuclear Medicine and Molecular Imaging 45 989-998Molecular imaging of prostate cancer: Choosing the right agent
Rowe SP, Pomper MG, Gorin MA 2018 May Journal of Nuclear Medicine 59 787-788Molecular Imaging of CXCL12 Promoter-driven HSV1-TK Reporter Gene Expression
Alon L, Kraitchman DL, Schär M, Cortez A, Yadav NN, Krimins R, Johnston PV, McMahon MT, van Zijl PC, Nimmagadda S, Pomper MG, Bulte JW, Gilad AA 2018 Mar Biotechnology and Bioprocess Engineering 23 208-217Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia
Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U 2018 Feb Molecular psychiatry 23 323-334Phenols as Diamagnetic T2-Exchange Magnetic Resonance Imaging Contrast Agents
Zhang J, Li Y, Slania S, Yadav NN, Liu J, Wang R, Zhang J, Pomper MG, van Zijl PC, Yang X, Liu G 2018 Jan Chemistry - A European Journal 24 1259-1263Future cancer research priorities in the USA: a Lancet Oncology Commission
Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A 2017 Nov The Lancet Oncology 18 e653-e706Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma
Zamboni CG, Kozielski KL, Vaughan HJ, Nakata MM, Kim J, Higgins LJ, Pomper MG, Green JJ 2017 Oct Journal of Controlled Release 263 18-28Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas
Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP 2017 Oct Clinical nuclear medicine 42 e433-e435Cardiosphere-Derived Cells Demonstrate Metabolic Flexibility That Is Influenced by Adhesion Status
Afzal J, Chan A, Karakas MF, Woldemichael K, Vakrou S, Guan Y, Rathmell J, Wahl R, Pomper M, Foster DB, Aon MA, Tsui B, O'Rourke B, Abraham MR 2017 Oct JACC: Basic to Translational Science 2 543-560Chemogenetics revealed: DREADD occupancy and activation via converted clozapine
Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M 2017 Aug Science 357 503-507Defining the clinical utility of PSMA-targeted PET imaging of prostate cancer
Gorin MA, Pomper MG, Pienta KJ, Rowe SP 2017 Aug BJU International 120 160-161Imaging of Prostate-Specific Membrane Antigen Using [18F]DCFPyL
Rowe SP, Gorin MA, Pomper MG 2017 Jul PET Clinics 12 289-296High Serum Stability of Collagen Hybridizing Peptides and Their Fluorophore Conjugates
Bennink LL, Smith DJ, Foss CA, Pomper MG, Li Y, Yu SM 2017 Jun Molecular Pharmaceutics 14 1906-1915Clinical Experience with 18F-Labeled Small Molecule Inhibitors of Prostate-Specific Membrane Antigen
Rowe SP, Gorin MA, Salas Fragomeni RA, Drzezga A, Pomper MG 2017 Apr PET Clinics 12 235-241Rapid PD-L1 detection in tumors with PET using a highly specific peptide
Chatterjee S, Lesniak WG, Miller MS, Lisok A, Sikorska E, Wharram B, Kumar D, Gabrielson M, Pomper MG, Gabelli SB, Nimmagadda S 2017 Jan Biochemical and Biophysical Research Communications 483 258-263Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging
Shim MK, Yoon HY, Ryu JH, Koo H, Lee S, Park JH, Kim JH, Lee S, Pomper MG, Kwon IC, Kim K 2016 Nov Angewandte Chemie - International Edition 55 14698-14703Development and application of a novel model system to study "active" and "passive" tumor targeting
Mukherjee A, Kumar B, Hatano K, Russell LM, Trock BJ, Searson PC, Meeker AK, Pomper MG, Lupold SE 2016 Oct Molecular Cancer Therapeutics 15 2541-2550Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation
He QL, Minn I, Wang Q, Xu P, Head SA, Datan E, Yu B, Pomper MG, Liu JO 2016 Sep Angewandte Chemie - International Edition 55 12035-12039Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor
Moldovan RP, Teodoro R, Gao Y, Deuther-Conrad W, Kranz M, Wang Y, Kuwabara H, Nakano M, Valentine H, Fischer S, Pomper MG, Wong DF, Dannals RF, Brust P, Horti AG 2016 Sep Journal of Medicinal Chemistry 59 7840-7855An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [18F]DCFPyL
Ravert HT, Holt DP, Chen Y, Mease RC, Fan H, Pomper MG, Dannals RF 2016 Sep Journal of Labelled Compounds and Radiopharmaceuticals 439-450Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands
Subedi M, Minn I, Chen J, Kim YH, Ok K, Jung YW, Pomper MG, Byun Y 2016 Aug European Journal of Medicinal Chemistry 118 208-218Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance
Chen Y, Lisok A, Chatterjee S, Wharram B, Pullambhatla M, Wang Y, Sgouros G, Mease RC, Pomper MG 2016 Jul Bioconjugate Chemistry 27 1655-1662Computed tomography appearance of renal hybrid oncocytic/chromophobe tumors
Bhatnagar A, Rowe SP, Gorin MA, Pomper MG, Fishman EK, Allaf ME 2016 Jul Journal of computer assisted tomography 40 513-516Targeted imaging of the atypical chemokine receptor 3 (ACKR3/CXCR7) in human cancer xenografts
Azad BB, Lisok A, Chatterjee S, Poirier JT, Pullambhatla M, Luker GD, Pomper MG, Nimmagadda S 2016 Jun Journal of Nuclear Medicine 57 981-988PSMA-targeted imaging of prostate cancer: The best is yet to come
Gorin MA, Pomper MG, Rowe SP 2016 May BJU International 117 715-716Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform
Lesniak WG, Oskolkov N, Song X, Lal B, Yang X, Pomper M, Laterra J, Nimmagadda S, McMahon MT 2016 Apr Nano Letters 16 2248-2253Critical Length of PEG Grafts on lPEI/DNA Nanoparticles for Efficient in Vivo Delivery
Williford JM, Archang MM, Minn I, Ren Y, Wo M, Vandermark J, Fisher PB, Pomper MG, Mao HQ 2016 Apr ACS Biomaterials Science and Engineering 2 567-578ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer
You DG, Deepagan VG, Um W, Jeon S, Son S, Chang H, Yoon HI, Cho YW, Swierczewska M, Lee S, Pomper MG, Kwon IC, Kim K, Park JH 2016 Mar Scientific reports 6Characterization of a novel metastatic prostate cancer cell line of LNCaP origin
Castanares MA, Copeland BT, Chowdhury WH, Liu MM, Rodriguez R, Pomper MG, Lupold SE, Foss CA 2016 Feb Prostate 76 215-225[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma
Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA, Sysa-Shah P, Lewis WD, Ahn HH, Wang Y, Banerjee SR, Mease RC, Nimmagadda S, Allaf ME, Pomper MG, Yang X 2016 Oncotarget 7 56471-56479Ultrahigh affinity Raman probe for targeted live cell imaging of prostate cancer
Li M, Banerjee SR, Zheng C, Pomper MG, Barman I 2016 Chemical Science 7 6779-6785A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
Chatterjee S, Lesniak WG, Gabrielson M, Lisok A, Wharram B, Sysa-Shah P, Azad BB, Pomper MG, Nimmagadda S 2016 Oncotarget 7 10215-10227Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Rowe SP, Gorin MA, Hammers HJ, Som Javadi M, Hawasli H, Szabo Z, Cho SY, Pomper MG, Allaf ME 2015 Dec Annals of Nuclear Medicine 29 877-882Prostate-specific membrane antigen as a target for cancer imaging and therapy
Kiess AP, Banerjee SR, Mease RC, Rowe SP, Rao A, Foss CA, Chen Y, Yang X, Cho SY, Nimmagadda S, Pomper MG 2015 Sep Quarterly Journal of Nuclear Medicine and Molecular Imaging 59 241-268Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen
Kiess AP, Minn I, Chen Y, Hobbs R, Sgouros G, Mease RC, Pullambhatla M, Shen CJ, Foss CA, Pomper MG 2015 Sep Journal of Nuclear Medicine 56 1401-1407Tumor-specific expression and detection of a CEST reporter gene
Minn I, Bar-Shir A, Yarlagadda K, Bulte JW, Fisher PB, Wang H, Gilad AA, Pomper MG 2015 Aug Magnetic resonance in medicine 74 544-54918F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer
Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, Guner G, Munari E, Partin AW, Pavlovich CP, Han M, Carter HB, Bivalacqua TJ, Blackford A, Holt D, Dannals RF, Netto GJ, Lodge MA, Mease RC, Pomper MG, Cho SY 2015 Jul Journal of Nuclear Medicine 56 1003-1010In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs
Röck R, Bachmann V, Bhang HE, Malleshaiah M, Raffeiner P, Mayrhofer JE, Tschaikner PM, Bister K, Aanstad P, Pomper MG, Michnick SW, Stefan E 2015 Jun Scientific reports 5Design and assembly of supramolecular dual-modality nanoprobes
Liu S, Zhang P, Ray Banerjee S, Xu J, Pomper MG, Cui H 2015 Jun Nanoscale 7 9462-9466Molecular imaging of inflammation in the ApoE -/- mouse model of atherosclerosis with IodoDPA
Foss CA, Bedja D, Mease RC, Wang H, Kass DA, Chatterjee S, Pomper MG 2015 May Biochemical and Biophysical Research Communications 461 70-75[125I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR
Gao Y, Mease RC, Olson TT, Kellar KJ, Dannals RF, Pomper MG, Horti AG 2015 May Nuclear Medicine and Biology 42 488-493Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study
Coughlin JM, Wang Y, Munro CA, Ma S, Yue C, Chen S, Airan R, Kim PK, Adams AV, Garcia C, Higgs C, Sair HI, Sawa A, Smith G, Lyketsos CG, Caffo B, Kassiou M, Guilarte TR, Pomper MG 2015 Feb Neurobiology of Disease 74 58-65Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Yang X, Minn I, Rowe SP, Banerjee SR, Gorin MA, Brummet M, Lee HS, Koo SM, Sysa-Shah P, Mease RC, Nimmagadda S, Allaf ME, Pomper MG 2015 Oncotarget 6 33733-33742Tuning phenols with Intra-Molecular bond Shifted HYdrogens (IM-SHY) as diaCEST MRI contrast agents
Yang X, Yadav NN, Song X, Ray Banerjee S, Edelman H, Minn I, van Zijl PC, Pomper MG, McMahon MT 2014 Nov Chemistry (Weinheim an der Bergstrasse, Germany) 20 15824-15832Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)
Woodard LE, De Silva RA, Behnam Azad B, Lisok A, Pullambhatla M, Lesniak WG, Mease RC, Pomper MG, Nimmagadda S 2014 Aug Nuclear Medicine and Biology 41 552-561Evaluation of prostate-specific membrane antigen as an imaging reporter
Castanares MA, Mukherjee A, Chowdhury WH, Liu M, Chen Y, Mease RC, Wang Y, Rodriguez R, Lupold SE, Pomper MG 2014 May Journal of Nuclear Medicine 55 805-811A red-shifted fluorescent substrate for aldehyde dehydrogenase
Minn I, Wang H, Mease RC, Byun Y, Yang X, Wang J, Leach SD, Pomper MG 2014 Apr Nature communications 518F-ASEM, a radiolabeled antagonist for imaging the aα7-nicotinic acetylcholine receptor with PET
Horti AG, Gao Y, Kuwabara H, Wang Y, Abazyan S, Yasuda RP, Tran T, Xiao Y, Sahibzada N, Holt DP, Kellar KJ, Pletnikov MV, Pomper MG, Wong DF, Dannals RF 2014 Apr Journal of Nuclear Medicine 55 672-67764Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer
Banerjee SR, Pullambhatla M, Foss CA, Nimmagadda S, Ferdani R, Anderson CJ, Mease RC, Pomper MG 2014 Mar Journal of Medicinal Chemistry 57 2657-2669Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis
Foerster BR, Carlos RC, Dwamena BA, Callaghan BC, Petrou M, Edden RA, Mohamed MA, Welsh RC, Barker PB, Feldman EL, Pomper MG 2014 Feb Annals of Clinical and Translational Neurology 1 107-114Imaging Axl expression in pancreatic and prostate cancer xenografts
Nimmagadda S, Pullambhatla M, Lisok A, Hu C, Maitra A, Pomper MG 2014 Jan Biochemical and Biophysical Research Communications 443 635-640Noninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713
Foss CA, Harper JS, Wang H, Pomper MG, Jain SK 2013 Dec Journal of Infectious Diseases 208 2067-2074Nanoparticles for cancer imaging: The good, the bad, and the promise
Chapman S, Dobrovolskaia M, Farahani K, Goodwin A, Joshi A, Lee H, Meade T, Pomper M, Ptak K, Rao J, Singh R, Sridhar S, Stern S, Wang A, Weaver JB, Woloschak G, Yang L 2013 Oct Nano Today 8 454-460Molecular imaging of conscious, unrestrained mice with AwakeSPECT
Baba JS, Endres CJ, Foss CA, Nimmagadda S, Jung H, Goddard JS, Lee S, McKisson J, Smith MF, Stolin AV, Weisenberger AG, Pomper MG 2013 Jun Journal of Nuclear Medicine 54 969-976Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression
Bar-Shir A, Liu G, Liang Y, Yadav NN, McMahon MT, Walczak P, Nimmagadda S, Pomper MG, Tallman KA, Greenberg MM, Van Zijl PC, Bulte JW, Gilad AA 2013 Jan Journal of the American Chemical Society 135 1617-1624PET imaging in prostate cancer: Focus on prostate-specific membrane antigen
Mease RC, Foss CA, Pomper MG 2013 Current topics in medicinal chemistry 13 951-962Influence of bioluminescence imaging dynamics by dluciferin uptake and efflux mechanisms
Zhang Y, Pullambhatla M, Laterra J, Pomper MG 2012 Nov Molecular Imaging 11 499-506PSMA-targeted theranostic nanoplex for prostate cancer therapy
Chen Z, Penet MF, Nimmagadda S, Li C, Banerjee SR, Winnard PT, Artemov D, Glunde K, Pomper MG, Bhujwalla ZM 2012 Sep ACS Nano 6 7752-7762Targeting collagen strands by photo-triggered triple-helix hybridization
Li Y, Foss CA, Summerfield DD, Doyle JJ, Torok CM, Dietz HC, Pomper MG, Yu SM 2012 Sep Proceedings of the National Academy of Sciences of the United States of America 109 14767-14772Diagnostic Accuracy Using Diffusion Tensor Imaging in the Diagnosis of ALS. A Meta-analysis
Foerster BR, Dwamena BA, Petrou M, Carlos RC, Callaghan BC, Pomper MG 2012 Sep Academic radiology 19 1075-1086Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
Krishnamachary B, Penet MF, Nimmagadda S, Mironchik Y, Raman V, Solaiyappan M, Semenza GL, Pomper MG, Bhujwalla ZM 2012 Aug PloS one 7Ovarian cancer gene therapy using HPV-16 Pseudovirion carrying the HSV-tk gene
Hung CF, Chiang AJ, Tsai HH, Pomper MG, Kang TH, Roden RR, Wu TC 2012 Jul PloS one 7Decreased microglial activation in MS patients treated with glatiramer acetate
Ratchford JN, Endres CJ, Hammoud DA, Pomper MG, Shiee N, McGready J, Pham DL, Calabresi PA 2012 Jun Journal of neurology 259 1199-1205[32P]ATP inhibits the growth of xenografted tumors in nude mice
Cheng Y, Senthamizhchelvan S, Agarwal R, Green GM, Mease RC, Sgouros G, Huso DL, Pomper MG, Meltzer SJ, Abraham JM 2012 May Cell Cycle 11 1878-1882Cancer imaging: Gene transcription-based imaging and therapeutic systems
Bhang HE, Pomper MG 2012 May International Journal of Biochemistry and Cell Biology 44 684-689Mechanisms of dendritic cell trafficking across the blood-brain barrier
Sagar D, Foss C, El Baz R, Pomper MG, Khan ZK, Jain P 2012 Mar Journal of Neuroimmune Pharmacology 7 74-94Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions
Harper J, Skerry C, Davis SL, Tasneen R, Weir M, Kramnik I, Bishai WR, Pomper MG, Nuermberger EL, Jain SK 2012 Feb Journal of Infectious Diseases 205 595-602Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans
Endres CJ, Coughlin JM, Gage KL, Watkins CC, Kassiou M, Pomper MG 2012 Feb Journal of Nuclear Medicine 53 330-335Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer
Bařinka C, Rojas C, Slusher B, Pomper M 2012 Feb Current Medicinal Chemistry 19 856-870Novel parametric PET image quantification using texture and shape analysis
Rahmim A, Coughlin J, Gonzalez M, Endres CJ, Zhou Y, Wong DF, Wahl RL, Sossi V, Pomper MG 2012 2227-2230A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA)
Banerjee SR, Pullambhatla M, Shallal H, Lisok A, Mease RC, Pomper MG 2011 Dec Oncotarget 2 1244-1253CuInSe/ZnS core/shell NIR quantum dots for biomedical imaging
Park J, Dvoracek C, Lee KH, Galloway JF, Bhang HE, Pomper MG, Searson PC 2011 Nov Small 7 3148-3152Novel substrate-based inhibitors of human glutamate carboxypeptidase II with enhanced lipophilicity
Plechanovová A, Byun Y, Alquicer G, Škultétyová L, Mlčochová P, Němcová A, Kim HJ, Navrátil M, Mease R, Lubkowski J, Pomper M, Konvalinka J, Rulíšek L, Bařinka C 2011 Nov Journal of Medicinal Chemistry 54 7535-7546Probing in vivo trafficking of polymer/DNA micellar nanoparticles using SPECT/CT imaging
Patil RR, Yu J, Banerjee SR, Ren Y, Leong D, Jiang X, Pomper M, Tsui B, Kraitchman DL, Mao HQ 2011 Sep Molecular Therapy 19 1626-1635Imaging CXCR4 expression in human cancer xenografts: Evaluation of monocyclam64Cu-AMD3465
De Silva RA, Peyre K, Pullambhatla M, Fox JJ, Pomper MG, Nimmagadda S 2011 Jun Journal of Nuclear Medicine 52 986-993Strong inhibition of xenografted tumor growth by low-level doses of [32P]ATP
Cheng Y, Yang J, Agarwal R, Green GM, Mease RC, Pomper MG, Meltzer SJ, Abraham JM 2011 Jun Oncotarget 2 461-466A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy
Hobbs RF, Baechler S, Fu DX, Esaias C, Pomper MG, Ambinder RF, Sgouros G 2011 Jun Medical physics 38 2892-2903Reference tissue modeling with parameter coupling: Application to a study of SERT binding in HIV
Endres CJ, Hammoud DA, Pomper MG 2011 Apr Physics in medicine and biology 56 2499-2513The evolution of imaging in cancer: Current state and future challenges
Higgins LJ, Pomper MG 2011 Feb Seminars in oncology 38 3-15Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression
Bhang HE, Gabrielson KL, Laterra J, Fisher PB, Pomper MG 2011 Jan Nature medicine 17 123-129A robust approach to enhance tumor-selective accumulation of nanoparticles
Qiao Y, Huang X, Nimmagadda S, Bai R, Staedtke V, Foss CA, Cheong I, Holdhoff M, Kato Y, Pomper MG, Riggins GJ, Kinzler KW, Diaz LA, Vogelstein B, Zhou S 2011 Oncotarget 2 59-68Compact CdZnTe-based gamma camera for prostate cancer imaging
Cui Y, Lall T, Tsui B, Yu J, Mahler G, Bolotnikov A, Vaska P, De Geronimo G, O'Connor P, Meinken G, Joyal J, Barrettf J, Camarda G, Hossain A, Kim KH, Yang G, Pomper M, Cho S, Weisman K, Seo Y, Babich J, LaFrance N, James RB 2011Effect of nitroxoline on angiogenesis and growth of human bladder cancer
Shim JS, Matsui Y, Bhat S, Nacev BA, Xu J, Bhang HE, Dhara S, Han KC, Chong CR, Pomper MG, So A, Liu JO 2010 Dec Journal of the National Cancer Institute 102 1855-1873Improved syntheses of precursors for PET radioligands [18F]XTRA and [18F]AZAN
Gao Y, Wang H, Mease RC, Pomper MG, Horti AG 2010 Oct Tetrahedron Letters 51 5333-533568Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer
Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, Horti A, Mease RC, Pomper MG 2010 Jul Journal of Medicinal Chemistry 53 5333-5341Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma
Joyal JL, Barrett JA, Marquis JC, Chen J, Hillier SM, Maresca KP, Boyd M, Gage K, Nimmagadda S, Kronauge JF, Friebe M, Dinkelborg L, Stubbs JB, Stabin MG, Mairs R, Pomper MG, Babich JW 2010 May Cancer research 70 4045-4053Molecular imaging: Techniques and current clinical applications
Bonekamp D, Hammoud DA, Pomper MG 2010 May Applied Radiology 39 10-21Positron emission tomography for serial imaging of the contused adult rat spinal cord
Tewarie RD, Yu J, Seidel J, Rahiem ST, Hurtado A, Tsui BM, Grotenhuis JA, Pomper MG, Oudega M 2010 Mar Molecular Imaging 9 108-116Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies
Wang H, Byun Y, Barinka C, Pullambhatla M, Bhang He, Fox JJ, Lubkowski J, Mease RC, Pomper MG 2010 Jan Bioorganic and Medicinal Chemistry Letters 20 392-397Magnetic resonance imaging features of pituicytomas: Analysis of 10 cases
Hammoud DA, Munter FM, Brat DJ, Pomper MG 2010 Journal of computer assisted tomography 34 757-761A low molecular weight PSMA-based fluorescent imaging agent for cancer
Chen Y, Dhara S, Banerjee SR, Byun Y, Pullambhatla M, Mease RC, Pomper MG 2009 Dec Biochemical and Biophysical Research Communications 390 624-629Synthesis of [125I]iodoDPA-713: A new probe for imaging inflammation
Wang H, Pullambhatla M, Guilarte TR, Mease RC, Pomper MG 2009 Nov Biochemical and Biophysical Research Communications 389 80-83Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans
Endres CJ, Pomper MG, James M, Uzuner O, Hammoud DA, Watkins CC, Reynolds A, Hilton J, Dannals RF, Kassiou M 2009 Aug Journal of Nuclear Medicine 50 1276-1282Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay
Zhang Y, Byun Y, Ren YR, Liu JO, Laterra J, Pomper MG 2009 Jul Cancer research 69 5867-5875Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT
Nimmagadda S, Pullambhatla M, Pomper MG 2009 Jul Journal of Nuclear Medicine 50 1124-1130EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J 2009 Jul Molecular Cancer Therapeutics 8 1751-1760Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells
Nimmagadda S, Glunde K, Pomper MG, Bhujwalla ZM 2009 May Neoplasia 11 477-484Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models
Pomper MG, Hammond H, Yu X, Ye Z, Foss CA, Lin DD, Fox JJ, Cheng L 2009 Mar Cell Research 19 370-379Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp
Zhang Y, Laterra J, Pomper MG 2009 Jan Neoplasia 11 96-101An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer
Song H, Shahverdi K, Huso DL, Wang Y, Fox JJ, Hobbs RF, Gimi B, Gabrielson KL, Pomper MG, Tsui BM, Bhujwalla Z, Reilly RT, Sgouros G 2008 Oct Clinical Cancer Research 14 6116-6124Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging
Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, Van Zijl PC 2008 Oct Magnetic resonance in medicine 60 842-849Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors
Fu DX, Tanhehco Y, Chen J, Foss CA, Fox JJ, Chong JM, Hobbs RF, Fukayama M, Sgouros G, Kowalski J, Pomper MG, Ambinder RF 2008 Oct Nature medicine 14 1118-1122In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat
Tipre DN, Fox JJ, Holt DP, Green G, Yu J, Pomper M, Dannals RF, Bengel FM 2008 Jul Journal of Nuclear Medicine 49 1189-1195Spatio-temporal modification of collagen scaffolds mediated by triple helical propensity
Wang AY, Foss CA, Leong S, Mo X, Pomper MG, Yu SM 2008 Jul Biomacromolecules 9 1755-1763Antibiotic treatment of tuberculosis: Old problems, new solutions
Jain SK, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR 2008 Jun Microbe 3 285-292Targeted Molecular Imaging in Oncology: Focus on Radiation Therapy
Nimmagadda S, Ford EC, Wong JW, Pomper MG 2008 Apr Seminars in Radiation Oncology 18 136-148Dysregulation of glutamate carboxypeptidase II in psychiatric disease
Guilarte TR, Hammoud DA, McGlothan JL, Caffo BS, Foss CA, Kozikowski AP, Pomper MG 2008 Feb Schizophrenia Research 99 324-332Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT
Diaz LA, Foss CA, Thornton K, Nimmagadda S, Endres CJ, Uzuner O, Seyler TM, Ulrich SD, Conway J, Bettegowda C, Agrawal N, Cheong I, Zhang X, Ladenson PW, Vogelstein BN, Mont MA, Zhou S, Kinzler KW, Vogelstein B, Pomper MG 2007 Oct PloS one 2ABCG2/BCRP expression modulates D-luciferin-based bioluminescence imaging
Zhang Y, Bressler JP, Neal J, Lal B, Bhang HE, Laterra J, Pomper MG 2007 Oct Cancer research 67 9389-9397Molecular neuroimaging: From conventional to emerging techniques
Hammoud DA, Hoffman JM, Pomper MG 2007 Oct RADIOLOGY 245 21-42In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla
Edden RA, Pomper MG, Barker PB 2007 Jun Magnetic resonance in medicine 57 977-982Virus-associated tumor imaging by induction of viral gene expression
Fu DX, Tanhehco YC, Chen J, Foss CA, Fox JJ, Lemas V, Chong JM, Ambinder RF, Pomper MG 2007 Mar Clinical Cancer Research 13 1453-1458Workshop on imaging science development for cancer prevention and preemption
Kelloff GJ, Sullivan DC, Baker H, Clarke LP, Nordstrom R, Tatum JL, Dorfman GS, Jacobs P, Berg CD, Pomper MG, Birrer MJ, Tempero M, Higley HR, Petty BG, Sigman CC, Maley C, Sharma P, Wax A, Ginsberg GG, Dannenberg AJ, Hawk ET, Messing EM, Grossman HB, Harisinghani M, Bigio IJ, Griebel D, Henson DE, Fabian CJ, Ferrara K, Fantini S, Schnall MD, Zujewski JA, Hayes W, Klein EA, DeMarzo A, Ocak I, Ketterling JA, Tempany C, Shtern F, Parnes HL, Gomez J, Srivastava S, Szabo E, Lam S, Seibel EJ, Massion P, McLennan G, Cleary K, Suh R, Burt RW, Pfeiffer RM, Hoffman JM, Roy HK, Wang T, Limburg PJ, El-Deiry WS, Papadimitrakopoulou V, Hittelman WN, MacAulay C, Veltri RW, Solomonzz D, Jeronimo J, Richards-Kortum R, Johnson KA, Viner JL, Stratton SP, Rajadhyaksha M, Dhawan A 2007 Cancer Biomarkers 3 1-33Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner
Wang Y, Seidel J, Tsui BM, Vaquero JJ, Pomper MG 2006 Nov Journal of Nuclear Medicine 47 1891-1900Proton MR spectroscopy in hyperhomocysteinemia with elevated blood methionine levels
Franco LP, Anderson J, Okoh J, Pomper MG, Braverman N, Barker PB 2006 Mar Journal of Magnetic Resonance Imaging 23 404-407Instrumentation development of a SPECT-CT system to image awake mice
Weisenberger AG, Kross B, Majewski S, Popov V, Smith MF, Tran VH, Welch B, Baba J, Goddard J, Pomper M, Tsui B 2006 3000-3003Pharmacologic and toxicologic evaluation of C. novyi-NT spores
Diaz LA, Cheong I, Foss CA, Zhang X, Peters BA, Agrawal N, Bettegowda C, Karim B, Liu G, Khan K, Huang X, Kohli M, Dang LH, Hwang P, Vogelstein A, Garrett-Mayer E, Kobrin B, Pomper M, Zhou S, Kinzler KW, Vogelstein B, Huso DL 2005 Dec Toxicological Sciences 88 562-575NAAG peptidase inhibitors and their potential for diagnosis and therapy
Zhou J, Neale JH, Pomper MG, Kozikowski AP 2005 Dec Nature Reviews Drug Discovery 4 1015-1026Glutamate carboxypeptidase II levels in rodent brain using [ 125I]DCIT quantitative autoradiography
Guilarte TR, McGlothan JL, Foss CA, Zhou J, Heston WD, Kozikowski AP, Pomper MG 2005 Oct Neuroscience letters 387 141-144In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: A biomarker of inflammation
Hardwick MJ, Chen MK, Baidoo K, Pomper MG, Guilarte TR 2005 Oct Molecular Imaging 4 432-438Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS
Hammoud DA, Endres CJ, Chander AR, Guilarte TR, Wong DF, Sacktor NC, McArthur JC, Pomper MG 2005 Aug Journal of NeuroVirology 11 346-355A restraint-free small animal SPECT imaging system with motion tracking
Weisenberger AG, Gleason SS, Goddard J, Kross B, Majewski S, Meikle SR, Paulus MJ, Pomper M, Popov V, Smith MF, Welch BL, Wojcik R 2005 Jun IEEE Transactions on Nuclear Science 52 638-644Potential applications of conventional and molecular imaging to biodefense research
Li K, Thomasson D, Ketai L, Contag C, Pomper M, Wright M, Bray M 2005 May Clinical Infectious Diseases 40 1471-1480Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy
Dubey P, Fatemi A, Barker PB, Degaonkar M, Troeger M, Zackowski K, Bastian A, Smith SA, Pomper MG, Moser HW, Raymond GV 2005 Jan Neurology 64 304-310Characteristic MR imaging changes in severe hypermethioninemic states [1]
Braverman NE, Mudd SH, Barker PB, Pomper MG 2005 American Journal of Neuroradiology 26 2705-2706A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation
Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Brenneman K, Pili R, Pomper M, Carducci MA, Wagner HN 2005 Bioconjugate Chemistry 16 43-50Synthesis and biodistribution of radiolabeled α7 nicotinic acetylcholine receptor ligands
Pomper MG, Phillips E, Fan H, McCarthy DJ, Keith RA, Gordon JC, Scheffel U, Dannals RF, Musachio JL 2005 Journal of Nuclear Medicine 46 326-334Advanced cancers: Eradication in all cases using 3-bromopyruvate therapy to deplete ATP
Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, Hullihen J, Pedersen PL 2004 Nov Biochemical and Biophysical Research Communications 324 269-275Bacteriolytic therapy can generate a potent immune response against experimental tumors
Agrawal N, Bettegowda C, Cheong I, Geschwind JF, Drake CG, Hipkiss EL, Tatsumi M, Dang LH, Diaz LA, Pomper M, Abusedera M, Wahl RL, Kinzler KW, Zhou S, Huso DL, Vogelstein B 2004 Oct Proceedings of the National Academy of Sciences of the United States of America 101 15172-15177A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier
Lin KS, Luu A, Baidoo KE, Hashemzadeh-Gargari H, Chen MK, Pili R, Pomper M, Carducci M, Wagner HN 2004 Bioconjugate Chemistry 15 1416-1423Dual low profile detector heads for a restraint free small animal SPECT imaging system
Weisenberger AG, Baba JS, Kross B, Gleason SS, Goddard J, Majewski S, Meikle SR, Paulus MJ, Pomper MG, Popov V, Smith MF, Welch BL, Wojcik R 2004 IEEE Nuclear Science Symposium Conference Record 4 2456-2460Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
Bettegowda C, Dang LH, Abrams R, Huso DL, Dillehay L, Cheong I, Agrawal N, Borzillary S, McCaffery JM, Watson EL, Lin KS, Bunz F, Baidoo K, Pomper MG, Kinzler KW, Vogelstein B, Zhou S 2003 Dec Proceedings of the National Academy of Sciences of the United States of America 100 15083-15088Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging
Ouwerkerk R, Bleich KB, Gillen JS, Pomper MG, Bottomley PA 2003 May RADIOLOGY 227 529-537Spinal meningioma causing diffuse leptomeningeal enhancement
Lucey BP, Tihan T, Pomper MG, Olivi A, Laterra J 2003 Jan Neurology 60 350-351Astroblastoma: Radiologic-pathologic correlation and distinction from ependymoma
Port JD, Brat DJ, Burger PC, Pomper MG 2002 American Journal of Neuroradiology 23 243-247Diffusion tensor MR imaging of the brain and white matter tractography
Melhem ER, Mori S, Mukundan G, Kraut MA, Pomper MG, Van Zijl PC 2002 American Journal of Roentgenology 178 3-16Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging
Mori S, Frederiksen K, Van Zijl PC, Stieltjes B, Kraut MA, Solaiyappan M, Pomper MG 2002 Annals of Neurology 51 377-380Chordoid glioma: A neoplasm unique to the hypothalamus and anterior third ventricle
Pomper MG, Passe TJ, Burger PC, Scheithauer BW, Brat DJ 2001 American Journal of Neuroradiology 22 464-469New techniques in magnetic resonance imaging of brain tumors
Pomper MG, Port JD 2001 Neuroimaging Clinics of North America 11 501-525Central nervous system vasculitis as a complication of refractory dermatomyositis
Regan M, Haque U, Pomper M, Pardo C, Stone J 2001 Journal of Rheumatology 28 207-211Quantification and minimization of magnetic susceptibility artifacts on GRE images
Port JD, Pomper MG 2000 Journal of computer assisted tomography 24 958-964CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography
Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB 1999 American Journal of Neuroradiology 20 75-85Histoplasmosis mimicking vasculitis of the central nervous system
Stone JH, Pomper MG, Hellmann DB 1998 Aug Journal of Rheumatology 25 1644-1648